Literature DB >> 28017495

Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.

Canhua Jiang1, Fulai Yuan1, Jie Wang2, Limeng Wu1.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common solid tumor in the oral cavity. Development and progression of OSCC is associated with the elevated presence of inhibitory M2 type tumor-associated macrophages (TAMs). However, the underlying mechanism leading to the enrichment of M2 TAMs and the pathway through which TAMs foster tumor progression are still unclear. In this study, we harvested TAMs and tumor cells from primary OSCC resections of stage II and stage III patients. We showed that compared to peritumoral macrophages, TAMs presented upregulated expression of PD-L1 and elevated capacity in inducing T cell apoptosis. The level of PD-L1 expression directly correlated with the level of T cell apoptosis. Interestingly, peripheral blood monocytes with low initial PD-L1 level had upregulated PD-L1 expression and acquired the ability to induce T cell apoptosis, after incubation with primary tumor cells from OSCC patients. The PD-L1 expression by monocytes depended on interleukin 10 (IL-10), since blockade of IL-10 in the tumor-monocyte coculture abrogated PD-L1 upregulation. IL-10 mRNA expression in tumor cells and monocytes also preceded PD-L1 mRNA expression in monocytes. Furthermore, the IL-10 concentration in the tumor microenvironment directly correlated with the PD-L1 level on TAMs. Together, these results suggest that OSCC could directly suppress antitumor T cell immunity through conditioning TAMs.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Macrophages; Oral squamous cell carcinoma; PD-L1

Mesh:

Substances:

Year:  2016        PMID: 28017495     DOI: 10.1016/j.imbio.2016.12.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  28 in total

Review 1.  Mechanism of tumour microenvironment in the progression and development of oral cancer.

Authors:  Mohd Mughees; Anindita Sengupta; Sapna Khowal; Saima Wajid
Journal:  Mol Biol Rep       Date:  2021-01-25       Impact factor: 2.316

Review 2.  Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics.

Authors:  Hirohito Yamaguchi; Jung-Mao Hsu; Wen-Hao Yang; Mien-Chie Hung
Journal:  Nat Rev Clin Oncol       Date:  2022-02-07       Impact factor: 66.675

Review 3.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 4.  CMTM6 as a master regulator of PD-L1.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani
Journal:  Cancer Immunol Immunother       Date:  2022-03-16       Impact factor: 6.630

5.  Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.

Authors:  Pei Liang; Susanne M Henning; Tristan Grogan; David Elashoff; Huihui Ye; Pinchas Cohen; William J Aronson
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-01-24       Impact factor: 5.455

6.  OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.

Authors:  Xin Pang; Sha-Sha Wang; Mei Zhang; Jian Jiang; Hua-Yang Fan; Jia-Shun Wu; Hao-Fan Wang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Cancer Immunol Immunother       Date:  2020-10-26       Impact factor: 6.968

7.  Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis.

Authors:  Ramy R Saleh; Jordan L Scott; Nicholas Meti; Danielle Perlon; Rouhi Fazelzad; Alberto Ocana; Eitan Amir
Journal:  Mol Diagn Ther       Date:  2022-02-01       Impact factor: 4.074

Review 8.  Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.

Authors:  Ramez Philips; Chihun Han; Brian Swendseid; Joseph Curry; Athanassios Argiris; Adam Luginbuhl; Jennifer Johnson
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response.

Authors:  Magali Champion; Kevin Brennan; Tom Croonenborghs; Andrew J Gentles; Nathalie Pochet; Olivier Gevaert
Journal:  EBioMedicine       Date:  2017-12-01       Impact factor: 8.143

10.  Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4.

Authors:  Shinji Yamada; Shunsuke Itai; Mika K Kaneko; Yukinari Kato
Journal:  Biochem Biophys Rep       Date:  2018-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.